Cognitive Behavioral Therapy vs Acceptance and Commitment Therapy for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two online therapy methods, cognitive-behavioral therapy (CBT) and acceptance and commitment therapy (ACT), to determine which is more effective for treating major depressive disorder (MDD). Researchers will divide participants into two groups: one will receive CBT, and the other ACT, both over an 8-week period. The trial seeks individuals diagnosed with MDD who reside in California and have a stable internet connection for online sessions. Each therapy focuses on different strategies to manage thoughts and feelings, helping participants either change negative patterns or accept them while taking positive action. Participants will complete questionnaires throughout the study to track their progress.
As an unphased trial, this study provides a unique opportunity to enhance understanding of effective online therapies for MDD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on psychological treatments for depression, so it's best to discuss your medications with the study team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT) are safe and effective for treating depression. Studies have found that ACT reduces symptoms of depression and anxiety, improving mental health without major side effects. For instance, a study involving over 1,300 patients found that ACT significantly improved depression.
Similarly, CBT is known for its safety and effectiveness. It helps people change negative thought patterns, leading to better mental health. Research indicates that CBT is as effective as medication for treating depression and works well over the long term.
Both therapies have been tested in various formats, including online, and are generally well-tolerated, with few reports of negative effects. Participants usually do not experience major problems during treatment. Overall, these therapies are considered safe and helpful for managing depression.12345Why are researchers excited about this trial?
Researchers are excited about Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) for depression because they offer unique approaches compared to traditional medications and standard talk therapies. CBT focuses on identifying and changing negative thought patterns and behaviors, which can lead to improved mood and outlook. Meanwhile, ACT emphasizes accepting negative thoughts and feelings while committing to actions that align with personal values, promoting a more flexible mindset. These therapies provide non-pharmacological options that empower individuals to actively participate in their mental health journey, potentially leading to long-lasting benefits without medication side effects.
What evidence suggests that this trial's treatments could be effective for depression?
This trial will compare Acceptance and Commitment Therapy (ACT) with Cognitive Behavioral Therapy (CBT) for treating depression. Studies have shown that ACT can significantly reduce depression symptoms by helping individuals accept negative thoughts and focus on actions aligned with their personal values. Research indicates that ACT effectively manages depression, even when delivered online.
CBT is another proven treatment for depression, aiding individuals in recognizing and changing negative thinking patterns. A review of 115 studies demonstrated that CBT effectively treats depression, with benefits lasting up to six months after treatment. Both ACT and CBT are reliable options for reducing depression symptoms, and this trial will evaluate their effectiveness in separate treatment arms.12346Who Is on the Research Team?
Iony D Ezawa, PhD
Principal Investigator
University of Southern California
Are You a Good Fit for This Trial?
This trial is for individuals with major depressive disorder (MDD) who are comfortable receiving psychological treatment in an online group setting. Participants will be screened and evaluated to ensure they meet the study's requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intake Evaluation
Participants complete an intake evaluation to determine eligibility
Treatment
Participants receive 8 weeks of online group therapy (CBT or ACT)
Follow-up
Participants complete monthly follow-up surveys for 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Acceptance and Commitment Therapy
- Cognitive Behavioral Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor